Crescent Biopharma, Inc. (CBIO)
20.85
+1.40
(+7.20%)
USD |
NASDAQ |
Apr 17, 13:50
Crescent Biopharma Shareholders Equity (Quarterly) : 203.01M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Agenus, Inc. | -271.11M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
| Arrowhead Pharmaceuticals, Inc. | 568.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 240.29M |
| Total Liabilities (Quarterly) | 37.28M |
| Debt to Equity Ratio | 0.0081 |
| Current Ratio | 6.561 |
| Net Debt Paydown Yield | -0.08% |